Advertisement
Screener

VBI Vaccines Inc/BC Operating Income

VBI Vaccines Inc/BC Operating Income

VBI Vaccines Inc/BC reported Operating Income of -$11.75 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2024-05-15

  • VBI Vaccines Inc/BC operating income (loss) for the quarter ending 2024-03-31 was -$11.75M.
  • VBI Vaccines Inc/BC operating income (loss) for the quarter ending 2023-12-31 was -$13.36M.
  • VBI Vaccines Inc/BC operating income (loss) for the quarter ending 2023-09-30 was -$10.07M.
  • VBI Vaccines Inc/BC operating income (loss) for the quarter ending 2023-06-30 was -$36.97M.
  • VBI Vaccines Inc/BC operating income (loss) for fiscal 2023 was -$79.91M.
  • VBI Vaccines Inc/BC operating income (loss) for fiscal 2022 was -$81.82M.
  • VBI Vaccines Inc/BC operating income (loss) for fiscal 2021 was -$68.03M.
  • VBI Vaccines Inc/BC operating income (loss) for fiscal 2020 was -$43.62M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2024-03-31-$11.75M
10-Q · filed 2024-05-15
-$25.12M
derived: sum of 2 quarters · filed 2024-05-15
-$35.19M
derived: sum of 3 quarters · filed 2024-05-15
-$72.16M
derived: sum of 4 quarters · filed 2024-05-15
2023-12-31-$13.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-$23.43M
derived: sum of 2 quarters · filed 2024-04-16
-$60.41M
derived: sum of 3 quarters · filed 2024-04-16
-$79.91M
10-K · filed 2024-04-16
2023-09-30-$10.07M
10-Q · filed 2023-11-14
-$47.04M
derived: sum of 2 quarters · filed 2023-11-14
-$66.55M
10-Q · filed 2023-11-14
-$87.99M
derived: sum of 4 quarters · filed 2024-05-15
2023-06-30-$36.97M
10-Q · filed 2023-08-14
-$56.48M
10-Q · filed 2023-08-14
-$77.92M
derived: sum of 3 quarters · filed 2024-05-15
-$99.48M
derived: sum of 4 quarters · filed 2024-05-15
2023-03-31-$19.51M
10-Q · filed 2024-05-15
-$40.95M
derived: sum of 2 quarters · filed 2024-05-15
-$62.51M
derived: sum of 3 quarters · filed 2024-05-15
-$85.41M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$21.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-$43.00M
derived: sum of 2 quarters · filed 2024-04-16
-$65.90M
derived: sum of 3 quarters · filed 2024-04-16
-$81.82M
10-K · filed 2024-04-16
2022-09-30-$21.56M
10-Q · filed 2023-11-14
-$44.46M
derived: sum of 2 quarters · filed 2023-11-14
-$60.38M
10-Q · filed 2023-11-14
-$81.25M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$22.90M
10-Q · filed 2023-08-14
-$38.82M
10-Q · filed 2023-08-14
-$59.70M
derived: sum of 3 quarters · filed 2023-08-14
-$74.72M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$15.92M
10-Q · filed 2023-05-15
-$36.79M
derived: sum of 2 quarters · filed 2023-05-15
-$51.82M
derived: sum of 3 quarters · filed 2023-05-15
-$68.26M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$20.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
-$35.90M
derived: sum of 2 quarters · filed 2023-03-13
-$52.34M
derived: sum of 3 quarters · filed 2023-03-13
-$68.03M
10-K · filed 2023-03-13
2021-09-30-$15.02M
10-Q · filed 2022-11-10
-$31.46M
derived: sum of 2 quarters · filed 2022-11-10
-$47.16M
10-Q · filed 2022-11-10
-$61.37M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$16.44M
10-Q · filed 2022-08-08
-$32.14M
10-Q · filed 2022-08-08
-$46.35M
derived: sum of 3 quarters · filed 2022-08-08
-$58.20M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31-$15.70M
10-Q · filed 2022-05-09
-$29.91M
derived: sum of 2 quarters · filed 2022-05-09
-$41.76M
derived: sum of 3 quarters · filed 2022-05-09
-$49.90M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$14.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07
-$26.07M
derived: sum of 2 quarters · filed 2022-03-07
-$34.21M
derived: sum of 3 quarters · filed 2022-03-07
-$43.62M
10-K · filed 2022-03-07
2020-09-30-$11.85M
10-Q · filed 2021-11-08
-$20.00M
derived: sum of 2 quarters · filed 2021-11-08
-$29.41M
10-Q · filed 2021-11-08
-$39.58M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30-$8.14M
10-Q · filed 2021-08-02
-$17.55M
10-Q · filed 2021-08-02
-$27.72M
derived: sum of 3 quarters · filed 2021-08-02
-$43.87M
derived: sum of 4 quarters · filed 2021-08-02
2020-03-31-$9.41M
10-Q · filed 2021-05-10
-$19.58M
derived: sum of 2 quarters · filed 2021-05-10
-$35.72M
derived: sum of 3 quarters · filed 2021-05-10
-$47.99M
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31-$10.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
-$26.31M
derived: sum of 2 quarters · filed 2021-03-02
-$38.58M
derived: sum of 3 quarters · filed 2021-03-02
-$52.40M
10-K · filed 2021-03-02
2019-09-30-$16.14M
10-Q · filed 2020-11-02
-$28.41M
derived: sum of 2 quarters · filed 2020-11-02
-$42.23M
10-Q · filed 2020-11-02
-$60.74M
derived: sum of 4 quarters · filed 2020-11-02
2019-06-30-$12.27M
10-Q · filed 2020-07-31
-$26.09M
10-Q · filed 2020-07-31
-$44.60M
derived: sum of 3 quarters · filed 2020-07-31
-$59.14M
derived: sum of 4 quarters · filed 2020-07-31
2019-03-31-$13.82M
10-Q · filed 2020-05-06
-$32.33M
derived: sum of 2 quarters · filed 2020-05-06
-$46.87M
derived: sum of 3 quarters · filed 2020-05-06
-$62.60M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31-$18.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
-$33.05M
derived: sum of 2 quarters · filed 2020-03-05
-$48.78M
derived: sum of 3 quarters · filed 2020-03-05
-$60.41M
10-K · filed 2020-03-05
2018-09-30-$14.54M
10-Q · filed 2019-11-06
-$30.28M
derived: sum of 2 quarters · filed 2019-11-06
-$41.90M
10-Q · filed 2019-11-06
-$52.88M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30-$15.73M
10-Q · filed 2019-08-09
-$27.36M
10-Q · filed 2019-08-09
-$38.34M
derived: sum of 3 quarters · filed 2019-08-09
-$47.48M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$11.62M
10-Q · filed 2019-05-01
-$22.60M
derived: sum of 2 quarters · filed 2019-05-01
-$31.75M
derived: sum of 3 quarters · filed 2019-05-01
-$40.06M
derived: sum of 4 quarters · filed 2019-05-01
2017-12-31-$10.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
-$20.12M
derived: sum of 2 quarters · filed 2019-02-25
-$28.43M
derived: sum of 3 quarters · filed 2019-02-25
-$37.28M
10-K · filed 2019-02-25
2017-09-30-$9.14M
10-Q · filed 2018-11-09
-$17.45M
derived: sum of 2 quarters · filed 2018-11-09
-$26.30M
10-Q · filed 2018-11-09
-$34.97M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$8.31M
10-Q · filed 2018-07-26
-$17.16M
10-Q · filed 2018-07-26
-$25.82M
derived: sum of 3 quarters · filed 2018-07-26
-$33.56M
derived: sum of 4 quarters · filed 2018-07-26
2017-03-31-$8.85M
10-Q · filed 2018-05-01
-$17.51M
derived: sum of 2 quarters · filed 2018-05-01
-$25.25M
derived: sum of 3 quarters · filed 2018-05-01
-$31.13M
derived: sum of 4 quarters · filed 2018-05-01
2016-12-31-$8.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$16.41M
derived: sum of 2 quarters · filed 2018-02-26
-$22.29M
derived: sum of 3 quarters · filed 2018-02-26
-$24.85M
10-K · filed 2018-02-26
2016-09-30-$7.74M
10-Q · filed 2017-11-13
-$13.62M
derived: sum of 2 quarters · filed 2017-11-13
-$16.18M
10-Q · filed 2017-11-13
2016-06-30-$5.88M
10-Q · filed 2017-07-31
-$8.45M
10-Q · filed 2017-07-31
2016-03-31-$2.56M
10-Q · filed 2017-05-15
2015-12-31-$23.76M
10-K · filed 2018-02-26